Wanhong Lu

First Affiliated Hospital of Xi'an Jiaotong University — China

Medicine · Health Sciences

4h-index281citations21works0.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Diseases and Glomerulopathies(8), Systemic Lupus Erythematosus Research(6), Iron Metabolism and Disorders(3), Erythropoietin and Anemia Treatment(3), Parathyroid Disorders and Treatments(2)

Publications21 total

Preliminary analysis of short-term real-world outcomes of telitacicept in high-risk IgA nephropathy
Frontiers in Medicine·2025Open Access
Baseline Characteristics and Treatment Patterns in Chinese Patients with Atypical Hemolytic Uremic Syndrome (aHUS): Preliminary Results from a Prospective, Observational Study
Journal of the American Society of Nephrology·2025
#2054 Observation of the therapeutic effect of finerenone, a novel non-steroidal mineralocorticoid receptor antagonist, in patients with non-diabetic CKD
Nephrology Dialysis Transplantation·2025
Observation of the therapeutic effect of finerenone, a novel non-steroidal mineralocorticoid receptor antagonist, in patients with non-diabetic CKD
Renal Failure·2025· 3 citedOpen Access
Efficacy and safety of belimumab in refractory and newly diagnosed active lupus nephritis patients: a real-world observational study
Clinical Kidney Journal·2025· 1 citedOpen Access
WCN25-679 PEGMOLESATIDE FOR THE TREATMENT OF ANEMIA IN NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS: POST-HOC ANALYSIS OF A PHASE 3 TRIAL
Kidney International Reports·2025Open Access
Randomized Trial of Pegmolesatide for the Treatment of Anemia in Patients With Nondialysis CKD
Kidney International Reports·2024· 4 citedOpen Access
Efficacy and Safety of Belimumab in Refractory and Newly Diagnosed Patients with Active Lupus Nephritis: A Real-World Retrospective Observational Study
Journal of the American Society of Nephrology·2024
Paricalcitol Capsule (HR081702) for Secondary Hyperparathyroidism (SHPT) in Stages 3 and 4 CKD: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study
Journal of the American Society of Nephrology·2024
#657 Obinutuzumab is effective for the treatment of frequently-relapsing/steroid-dependent minimal change disease in adults
Nephrology Dialysis Transplantation·2024· 1 citedOpen Access
#2043 Telitacicept in patients with IgA nephropathy
Nephrology Dialysis Transplantation·2024· 1 citedOpen Access
#1649 Obinutuzumab is effective for the treatment of rituximab-resistant membranous nephropathy
Nephrology Dialysis Transplantation·2024Open Access
Humoral Immune Responses Primed by the Alteration of Gut Microbiota Were Associated with Galactose-Deficient IgA1 Production in IgA Nephropathy
Journal of the American Society of Nephrology·2023
Clinical features and outcomes of patients with antineutrophil cytoplasmic antibody-positive systemic lupus erythematosus
Renal Failure·2023· 9 citedOpen Access
Bone marrow mesenchymal stem cell-derived exosomal miR-30e-5p ameliorates high-glucose induced renal proximal tubular cell pyroptosis by inhibiting ELAVL1
Renal Failure·2023· 40 citedOpen Access
Bone marrow mesenchymal stem cell-derived exosomal miR-30e-5p ameliorates high-glucose induced renal proximal tubular cell pyroptosis by inhibiting ELAVL1
Figshare·2023Open Access
Efficacy and Safety of Sevelamer Carbonate in Chinese Nondialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized, Double-Blind, Parallel-Group Study
Kidney Diseases·2022· 4 citedOpen Access
Pegmolesatide for the Treatment of Anemia in NDD-CKD Patients: A Multicenter Randomized Active-Controlled Phase 3 Trial
Journal of the American Society of Nephrology·2022· 1 cited
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
Kidney International·2022· 205 citedOpen Access
Analysis of the Expression of Exostosins and Clinicopathological Features in Membranous Lupus Nephritis in a Chinese Cohort
Kidney International Reports·2022· 12 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Huixian Li(8), Qinkai Chen(5), Xinfang Xie(5), Xueqing Yu(4), Liyi Xie(3), Xiaoyang Yu(3), Aicheng Yang(3), Hongyu Qiu(3), Xiaomei Peng(3), Jiping Sun(3), Hernán Trimarchi(2), Sean Barbour(2), Jicheng Lv(2), Ping Fu(2), Yaning Hao(2), Dan Niu(2), Ping Lan(2), Ying Wang(2), Wei Yang(2), Liang Yu(2)